These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33834919)

  • 21. A novel causal mediation analysis approach for zero-inflated mediators.
    Jiang M; Lee S; O'Malley AJ; Stern Y; Li Z
    Stat Med; 2023 Jun; 42(13):2061-2081. PubMed ID: 37071977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Change point detection in Cox proportional hazards mixture cure model.
    Wang B; Li J; Wang X
    Stat Methods Med Res; 2021 Feb; 30(2):440-457. PubMed ID: 32970523
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defective 3-parameter Gompertz model with frailty term for estimating cure fraction in survival data.
    Hajizadeh N; Baghestani AR; Pourhoseingholi MA; Khadem Maboudi AA
    J Biopharm Stat; 2023 Jan; 33(1):90-113. PubMed ID: 35671330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Semiparametric accelerated failure time cure rate mixture models with competing risks.
    Choi S; Zhu L; Huang X
    Stat Med; 2018 Jan; 37(1):48-59. PubMed ID: 28983935
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new cure rate regression framework for bivariate data based on the Chen distribution.
    de Oliveira RP; de Oliveira Peres MV; Martinez EZ; Alberto Achcar J
    Stat Methods Med Res; 2022 Dec; 31(12):2442-2455. PubMed ID: 36128911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inference on latent factor models for informative censoring.
    Ungolo F; van den Heuvel ER
    Stat Methods Med Res; 2022 May; 31(5):801-820. PubMed ID: 35077263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. geecure: An R-package for marginal proportional hazards mixture cure models.
    Niu Y; Wang X; Peng Y
    Comput Methods Programs Biomed; 2018 Jul; 161():115-124. PubMed ID: 29852954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term frailty modeling using a non-proportional hazards model: Application with a melanoma dataset.
    Calsavara VF; Milani EA; Bertolli E; Tomazella V
    Stat Methods Med Res; 2020 Aug; 29(8):2100-2118. PubMed ID: 31691640
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complete effect decomposition for an arbitrary number of multiple ordered mediators with time-varying confounders: A method for generalized causal multi-mediation analysis.
    Tai AS; Lin SH
    Stat Methods Med Res; 2023 Jan; 32(1):100-117. PubMed ID: 36321187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Integrated multiple mediation analysis: A robustness-specificity trade-off in causal structure.
    Tai AS; Lin SH
    Stat Med; 2021 Sep; 40(21):4541-4567. PubMed ID: 34114676
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bayesian shrinkage estimation of high dimensional causal mediation effects in omics studies.
    Song Y; Zhou X; Zhang M; Zhao W; Liu Y; Kardia SLR; Roux AVD; Needham BL; Smith JA; Mukherjee B
    Biometrics; 2020 Sep; 76(3):700-710. PubMed ID: 31733066
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Bayesian joint model for compositional mediation effect selection in microbiome data.
    Fu J; Koslovsky MD; Neophytou AM; Vannucci M
    Stat Med; 2023 Jul; 42(17):2999-3015. PubMed ID: 37173609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multilevel mediation analysis in R: A comparison of bootstrap and Bayesian approaches.
    Falk CF; Vogel TA; Hammami S; Miočević M
    Behav Res Methods; 2024 Feb; 56(2):750-764. PubMed ID: 36814007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling excess hazard with time-to-cure as a parameter.
    Boussari O; Bordes L; Romain G; Colonna M; Bossard N; Remontet L; Jooste V
    Biometrics; 2021 Dec; 77(4):1289-1302. PubMed ID: 32869288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Bayesian semiparametric latent variable approach to causal mediation.
    Kim C; Daniels M; Li Y; Milbury K; Cohen L
    Stat Med; 2018 Mar; 37(7):1149-1161. PubMed ID: 29250817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BayesGmed: An R-package for Bayesian causal mediation analysis.
    Yimer BB; Lunt M; Beasley M; Macfarlane GJ; McBeth J
    PLoS One; 2023; 18(6):e0287037. PubMed ID: 37314996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of censoring on learning Bayesian networks in survival modelling.
    Stajduhar I; Dalbelo-Basić B; Bogunović N
    Artif Intell Med; 2009 Nov; 47(3):199-217. PubMed ID: 19833488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Landmark cure rate models with time-dependent covariates.
    Shi H; Yin G
    Stat Methods Med Res; 2017 Oct; 26(5):2042-2054. PubMed ID: 28627311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Practical application of cure mixture model for long-term censored survivor data from a withdrawal clinical trial of patients with major depressive disorder.
    Arano I; Sugimoto T; Hamasaki T; Ohno Y
    BMC Med Res Methodol; 2010 Apr; 10():33. PubMed ID: 20412598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A functional proportional hazard cure rate model for interval-censored data.
    Shi H; Ma D; Faisal Beg M; Cao J
    Stat Methods Med Res; 2022 Jan; 31(1):154-168. PubMed ID: 34806480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.